Beatty Laboratory: In the News

Read the latest news and advances by the Beatty Laboratory

Cell riding2_2019.jpg

Bringing cancer immunotherapy to pancreatic cancer

JAN 2019 The Abramson Cancer Center to host symposium from April 11-12, 2019 on Immunology and Immunotherapy for Pancreatic Cancer.


Preclinical models for safety assessment of IO drugs

SEPT 2018 FDA-AACR Workshop on non-clinical models for safety assessment of immuno-oncology products. Gregory Beatty MD PhD speaks on the role of syngeneic mouse models.

Purple ribbon_2.jpg

Purplestride Philadelphia 2018

SEPT 2018 Gregory Beatty, MD PhD named honorary co-chair for the 2018 Purplestride Philadelphia held on Nov 3, 2018.


Innate immune agonists induce immunity against a “cold” tumor

MAR 2018 Combining two innate immune agonists stimulates productive anti-tumor immunity against an immunologically “cold” tumor without requirement for immune checkpoint blockade.


The underpinnings of liver metastasis

APR 2017 Through a SU2C Innovation Research Grant the Beatty Laboratory is investigating how cancer spreads to the liver and the impact of the liver on cancer therapy.